These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20880403)

  • 21. The effects of ethanol on pre-synaptic components of synaptic transmission in a model glutamatergic synapse: the crayfish neuromuscular junction.
    Strawn JR; Cooper RL
    Comp Biochem Physiol C Toxicol Pharmacol; 2002 Mar; 131(3):395-404. PubMed ID: 11912064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prejunctional inhibitory effect of suramin on neuromuscular transmission in vitro.
    Henning RH; Rowan EG; Braga MF; Nelemans A; Harvey AL
    Eur J Pharmacol; 1996 Apr; 301(1-3):91-7. PubMed ID: 8773451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Train-of-four fade during neuromuscular blockade induced by tubocurarine, succinylcholine or alpha-bungarotoxin in the rat isolated hemidiaphragm.
    Cheah LS; Gwee MC
    Clin Exp Pharmacol Physiol; 1988 Dec; 15(12):937-43. PubMed ID: 2854017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tubocurarine on end-plate current rundown and quantal content during rapid nerve stimulation in the snake.
    Harborne AJ; Bowman WC; Marshall IG
    Clin Exp Pharmacol Physiol; 1988 Jun; 15(6):479-90. PubMed ID: 3271621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of roxatidine on neuromuscular transmission.
    Bossa R; Chiericozzi M; Galatulas I; Salvatore G; Teli M; Baggio G; Castelli M
    In Vivo; 1995; 9(2):113-5. PubMed ID: 7548786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neuromuscular blocking activity of spectinomycin on the rat sciatic nerve-gastrocnemius muscle preparation.
    Renna G; Cagiano R; Fiore T; Cuomo V
    Pharmacol Res Commun; 1986 May; 18(5):451-7. PubMed ID: 3016766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The decrease of neuromuscular transmission by adenosine depends on previous neuromuscular depression.
    Ribeiro JA
    Arch Int Pharmacodyn Ther; 1982 Jan; 255(1):59-67. PubMed ID: 6280626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Safety Factor for Neuromuscular Transmission: Effects of Dimethylsulphoxide, Cannabinoids and Synaptic Homeostasis.
    Odierna GL; Phillips WD
    J Neuromuscul Dis; 2021; 8(5):831-844. PubMed ID: 34334412
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of CT 1341 (Althesin) with neuromuscular blocking drugs.
    de Temmerman P
    Acta Anaesthesiol Belg; 1974; 25(3):330-9. PubMed ID: 4466318
    [No Abstract]   [Full Text] [Related]  

  • 31. Doxapram and the neuromuscular junction.
    Pollard BJ; Randall NP; Pleuvry BJ
    Br J Anaesth; 1989 Jun; 62(6):664-8. PubMed ID: 2751921
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The actions of neuromuscular relaxants at hyperbaric pressures.
    Gountis-Bonikos C; Kendig JJ; Cohen EN
    Anesthesiology; 1977 Jul; 47(1):11-5. PubMed ID: 869244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Blocking effects of cycleanine dimethobromide on nerve ganglia and neuromuscular junctions (author's transl)].
    Lu YQ; Xu DZ; Mao YK; Wei X; Yang ZC
    Zhongguo Yao Li Xue Bao; 1981 Dec; 2(4):223-6. PubMed ID: 6462019
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacology and clinical use of neuromuscular blocking agents.
    DeGarmo BH; Dronen S
    Ann Emerg Med; 1983 Jan; 12(1):48-55. PubMed ID: 6295218
    [No Abstract]   [Full Text] [Related]  

  • 35. Stimulation-dependent release, breakdown, and action of endogenous ATP in mouse hemidiaphragm preparation: the possible role of ATP in neuromuscular transmission.
    Vizi ES; Nitahara K; Sato K; Sperlágh B
    J Auton Nerv Syst; 2000 Jul; 81(1-3):278-84. PubMed ID: 10869732
    [TBL] [Abstract][Full Text] [Related]  

  • 36. d-Tubocurarine sensitivities of a fast and a slow neuromuscular system of the rat.
    Storella RJ; Riker WF; Baker T
    Eur J Pharmacol; 1985 Nov; 118(1-2):181-4. PubMed ID: 4085548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of neuromuscular blocking agents: is the increased understanding of importance to the practising anaesthetist?
    Aglan MY; Pollard BJ
    Pharmacol Ther; 1995; 68(3):365-83. PubMed ID: 8788563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular blocking action of sodium nitroprusside alone and with d-tubocurarine.
    Diwan PV; Sharma PL; Varma YS
    Eur J Pharmacol; 1980 May; 63(2-3):183-5. PubMed ID: 6769683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuromuscular interaction between cisatracurium and mivacurium, atracurium, vecuronium or rocuronium administered in combination.
    Kim KS; Chun YS; Chon SU; Suh JK
    Anaesthesia; 1998 Sep; 53(9):872-8. PubMed ID: 9849281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by neosurugatoxin and omega-conotoxin of acetylcholine release and muscle and neuronal nicotinic receptors in mouse neuromuscular junction.
    Hong SJ; Tsuji K; Chang CC
    Neuroscience; 1992; 48(3):727-35. PubMed ID: 1318519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.